Cargando…
Correction: Shikonin inhibits cancer cell cycling by targeting Cdc25s
Autores principales: | Zhang, Shoude, Gao, Qiang, Li, Wei, Zhu, Luwei, Shang, Qianhan, Feng, Shuo, Jia, Junmei, Jia, Qiangqiang, Shen, Shuo, Su, Zhanhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197834/ https://www.ncbi.nlm.nih.gov/pubmed/37208659 http://dx.doi.org/10.1186/s12885-023-10976-2 |
Ejemplares similares
-
Shikonin inhibits cancer cell cycling by targeting Cdc25s
por: Zhang, Shoude, et al.
Publicado: (2019) -
Dual-Specificity Phosphatase CDC25B Was Inhibited by Natural Product HB-21 Through Covalently Binding to the Active Site
por: Zhang, Shoude, et al.
Publicado: (2018) -
Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site
por: Zhang, Shoude, et al.
Publicado: (2022) -
Correction: Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1
por: Zorman, Jernej, et al.
Publicado: (2016) -
Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1
por: Yin, Shu-Yi, et al.
Publicado: (2018)